You are here: Industry Insights > COVID-19

News List

HiFiBiO submits IND application for SARS-CoV-2 neutralising antibody to treat Covid-19 patients pharmaceutical-business-review
August 31, 2020
HiFiBiO Therapeutics announced the submission of an Investigational New Drug (IND) application with the US Food and Drug Administration (FDA) for a novel SARS-CoV-2 neutralizing antibody for the treatment of Covid-19 patients.
Further ￡8.4 million in funding given to UK researchers studying immune response to COVID-19 europeanpharmaceuticalreview
August 31, 2020
The funding is being split across three research projects that will hopefully improve the treatment of COVID-19 and inform the development of vaccines and therapeutics.
Study shows anticoagulation therapy beneficial for COVID-19 patients europeanpharmaceuticalreview
August 31, 2020
Researchers have demonstrated that all regimens of anticoagulants were far superior to no anticoagulants in COVID-19 patients.
FDA Authorizes First Diagnostic Test Where Results Can Be Read Directly From Testing Card americanpharmaceuticalreview
August 31, 2020
The U.S. Food and Drug Administration (FDA) has issued an emergency use authorization for the first antigen test where results can be read directly from the testing card, a similar design to some pregnancy tests.
RedHill Biopharma Announces Positive Recommendation from COVID-19 Study americanpharmaceuticalreview
August 31, 2020
RedHill Biopharma announced its U.S. Phase 2 study with opaganib (Yeliva?, ABC294640) in patients hospitalized with severe COVID-19 pneumonia, has successfully passed the first scheduled independent Safety Monitoring Committee (SMC) review.
Q BioMed Initiates GMP Production of Novel COVID-19 Therapeutic contractpharma
August 31, 2020
COVID-19 clinical trial planned for Q1 2021 supported by Canadian Government.
Active ingredient in insect repellent may protect against COVID-19: UK study expresspharma
August 31, 2020
Citriodiol had anti-viral properties if mixed with the virus in the liquid phase and on a test surface.
Gilead, AstraZeneca and Pfizer may be winners in race for COVID-19 therapeutics and vaccines: GlobalData expresspharma
August 31, 2020
More than 1,200 therapeutics and vaccines have entered the research and development (R&D) pipeline since January 2020, according to GlobalData, and that number grows every week.
US FDA broadens EUA for Veklury (remdesivir) to treat all hospitalised COVID-19 patients expresspharma
August 31, 2020
The expansion is supported by the FDA’s analysis of additional data from two randomised, controlled clinical trials that included patients with mild or moderate disease.
University of Sheffield joins UK Coronavirus Immunology Consortium for COVID-19 research expresspharma
August 31, 2020
The Sheffield team will investigate how the body’s immune system responds to infection and also examine how T cells contribute to immunity to the virus to prevent re-infection.